Osmohale^® in United Kingdom

Welcome to the United Kingdom homepage

The mannitol challenge test (Osmohale®) is an indirect osmotic bronchial challenge test that can be used to identify bronchial hyperresponsivesness, a key clinical feature of respiratory conditions such as asthma.

Osmohale is manufactured by Pharmaxis Ltd (Frenchs Forest, Sydney Australia) and is available as a standardised test kit containing pre-filled mannitol capsules and a hand held dry powder inhaler.

During a mannitol challenge test, the subject inhales increasing doses of mannitol with their lung function (forced expiratory volume in one second- FEV₁) measured after each dose to determine the level of bronchial hyperresponsiveness.

The mannitol challenge test should only be performed by a suitably trained healthcare professional. Please refer to the approved product information or summary of product characteristics for your country prior to performing this challenge test.

Please refer to the Approved Osmohale Product Information (PI) and Consumer Medicine Information attached below.

Osmohale is supplied in the UK through CHAPPER healthcare 

Phone:      01923 235 179

Email:       ukenquiries@chapperhealthcare.com

Website:   https://chapperhealthcare.com/contact-us/

To open an account with Chapper healthcare please complete the following forms and email them to ukenquiries@chapperhealthcare.com:

• Chapper healthcare New Customer Form
• Chapper healthcare Technical Agreement 

Medical Information:

Email: medinfo.uk@pharmaxis.com

SPC (Summary of Product Characteristics)

PIL (Patient Information Leaflet)